OstermannT, KrummenauerF, HeusserP, BoehmK. Health economic evaluation in complementary medicine: Development within the last decades concerning local origin and quality. Complement Ther Med, 2011; 19(6):289–302.
2.
OstermannT, BaarsE, McDaidD. Time to stand up and be counted: The need for an economic case for investment. Complement Ther Med, 2016; 27:137–138.
3.
OstermannT, BurkartJ, De JaegereS, et al.Overview and quality assessment of health economic evaluations for homeopathic therapy: An updated systematic review. Expert Rev Pharmacoecon Outcomes Res, 2024; 24(1):117–142.
4.
RoustaeiN. Application and interpretation of linear-regression analysis. Med Hypothesis Discov Innov Ophthalmol, 2024; 13(3):151–159.
5.
MaussnerN, TomasikMJ, SchusterR, OstermannT. On the preference for linear regression models in children: Results of a field study in elementary school children. J Exp Child Psychol, 2019; 178:30–40.
6.
ZouKH, TuncaliK, SilvermanSG. Correlation and simple linear regression. Radiology, 2003; 227(3):617–622.
7.
BergerB, SteckelbergA, MeyerG, et al.Training of patient and consumer representatives in the basic competencies of evidence-based medicine: A feasibility study. BMC Med Educ, 2010; 10(1):16.
8.
Stock-SchröerB, LangeS. Expectations of doctoral students in the field of medicine and health sciences towards a graduate school: An online cross-sectional survey in Germany. Front Med (Lausanne), 2024; 11:1481796.
9.
RoccettiM, GhiniV, CacciaguerraS. Interceptor: a tool for enabling large-scale simulation of software distribuited applications in a networked laboratory. In: 6th World Multiconference on Systemics, Cybernetics and Informatics. IIIS Press: Orlando, FL; 2002; pp. 242–246.
10.
EvstigneevMP, BuchelnikovAS, EvstigneevVP. The theory of interceptor-protector action of DNA binding drugs. Prog Biophys Mol Biol, 2019; 149:131–146.
11.
DavisMT, RobbinsMJ, LundayBJ. Approximate dynamic programming for missile defense interceptor fire control. European Journal of Operational Research, 2017; 259(3):873–886.
